Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma

Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.
Latest website image capture
Clouds background image

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-03-03T23:12:30.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-02-17T19:29:24.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new Phase 1/2 study of SL-701 for recurrent glioblastoma multiforme, including details about participant eligibility, treatment protocols, and study outcomes. Additionally, there is a notice regarding heavy traffic affecting NLM-NCBI services.
    Difference
    30%
    Check dated 2025-02-10T16:47:38.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.2%
    Check dated 2025-02-03T11:52:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T04:10:55.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T23:30:04.000Z thumbnail image

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma

Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.